Centerpoint Advisors’s Exelon EXC Stock Holding History

Centerpoint Advisors’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12	Closed	–	–	486
2023 Q3	$0	Hold	12	–	–	﹤0.01%	575
2023 Q2	$0	Hold	12	–	–	﹤0.01%	577
2023 Q1	$1K	Buy	+12	New	+$500	﹤0.01%	492
2022 Q2	–	Sell	-73	Closed	-$3K	–	403
2022 Q1	$3K	Sell	73 -235	-76%	-$9.96K	﹤0.01%	300
2021 Q4	$13K	Buy	+308	New	+$11.6K	0.01%	203

Other funds holding EXC

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Centerpoint Advisors's EXC Position: Q4 2023 in Review

Centerpoint Advisors sold out of Exelon (EXC) in Q4 2023, closing a stake of 12 shares.

Centerpoint Advisors first reported a position in EXC in Q4 2021 and held it in 5 quarters. The position peaked at $13K in Q4 2021. 1,017 funds tracked by Wall St. Rank hold EXC as of Q4 2023.

Centerpoint Advisors reported no remaining Exelon position as of Q4 2023 after selling out during the quarter.
Centerpoint Advisors sold 12 Exelon shares in Q4 2023.
Centerpoint Advisors first reported a position in Exelon in Q4 2021 and held it in 5 quarters.
Centerpoint Advisors's Exelon position peaked at $13K in Q4 2021.
1,017 funds tracked by Wall St. Rank held Exelon as of Q4 2023.

Based on Centerpoint Advisors's 13F filing for Q4 2023, filed 16 Jan 2024.